Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Insight Molecular Diagnostics (IMDX) Debt Ratio (2020 - 2025)

Insight Molecular Diagnostics (IMDX) has disclosed Debt Ratio for 6 consecutive years, with 0.02 as the latest value for Q4 2025.

  • Quarterly Debt Ratio rose 155.68% to 0.02 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.02 through Dec 2025, up 155.68% year-over-year, with the annual reading at 0.02 for FY2025, 155.68% up from the prior year.
  • Debt Ratio hit 0.02 in Q4 2025 for Insight Molecular Diagnostics, down from 0.02 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.07 in Q2 2021 to a low of 0.0 in Q3 2022.
  • Historically, Debt Ratio has averaged 0.01 across 5 years, with a median of 0.01 in 2021.
  • Biggest five-year swings in Debt Ratio: crashed 95.17% in 2022 and later surged 2737.24% in 2023.
  • Year by year, Debt Ratio stood at 0.01 in 2021, then plummeted by 87.48% to 0.0 in 2022, then soared by 2737.24% to 0.03 in 2023, then crashed by 78.97% to 0.01 in 2024, then surged by 155.68% to 0.02 in 2025.
  • Business Quant data shows Debt Ratio for IMDX at 0.02 in Q4 2025, 0.02 in Q3 2025, and 0.01 in Q2 2025.